Literature DB >> 26883559

Improving Tumor Treating Fields Treatment Efficacy in Patients With Glioblastoma Using Personalized Array Layouts.

Cornelia Wenger1, Ricardo Salvador2, Peter J Basser3, Pedro C Miranda2.   

Abstract

PURPOSE: To investigate tumors of different size, shape, and location and the effect of varying transducer layouts on Tumor Treating Fields (TTFields) distribution in an anisotropic model. METHODS AND MATERIALS: A realistic human head model was generated from MR images of 1 healthy subject. Four different virtual tumors were placed at separate locations. The transducer arrays were modeled to mimic the TTFields-delivering commercial device. For each tumor location, varying array layouts were tested. The finite element method was used to calculate the electric field distribution, taking into account tissue heterogeneity and anisotropy.
RESULTS: In all tumors, the average electric field induced by either of the 2 perpendicular array layouts exceeded the 1-V/cm therapeutic threshold value for TTFields effectiveness. Field strength within a tumor did not correlate with its size and shape but was higher in more superficial tumors. Additionally, it always increased when the array was adapted to the tumor's location. Compared with a default layout, the largest increase in field strength was 184%, and the highest average field strength induced in a tumor was 2.21 V/cm.
CONCLUSIONS: These results suggest that adapting array layouts to specific tumor locations can significantly increase field strength within the tumor. Our findings support the idea of personalized treatment planning to increase TTFields efficacy for patients with GBM.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26883559     DOI: 10.1016/j.ijrobp.2015.11.042

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

1.  Tumor Treating Fields for Ovarian Carcinoma: A Modeling Study.

Authors:  Edwin Lok; Pyay San; Victoria White; Olivia Liang; Page C Widick; Sindhu Pisati Reddy; Eric T Wong
Journal:  Adv Radiat Oncol       Date:  2021-05-17

2.  Clinical Potential of Nerve Input to Tumors: A Bioelectricity Perspective.

Authors:  Jade A Phillips; Charlotte Hutchings; Mustafa B A Djamgoz
Journal:  Bioelectricity       Date:  2021-03-16

3.  Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study.

Authors:  Anders Rosendal Korshoej; Frederik Lundgaard Hansen; Axel Thielscher; Gorm Burckhardt von Oettingen; Jens Christian Hedemann Sørensen
Journal:  PLoS One       Date:  2017-06-12       Impact factor: 3.240

4.  Analysis of physical characteristics of Tumor Treating Fields for human glioblastoma.

Authors:  Edwin Lok; Pyay San; Van Hua; Melissa Phung; Eric T Wong
Journal:  Cancer Med       Date:  2017-05-23       Impact factor: 4.452

5.  Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations.

Authors:  Anders Rosendal Korshoej; Frederik Lundgaard Hansen; Nikola Mikic; Gorm von Oettingen; Jens Christian Hedemann Sørensen; Axel Thielscher
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

6.  Diffuse intrinsic pontine glioma cells are vulnerable to low intensity electric fields delivered by intratumoral modulation therapy.

Authors:  Andrew Deweyert; Erin Iredale; Hu Xu; Eugene Wong; Susanne Schmid; Matthew O Hebb
Journal:  J Neurooncol       Date:  2019-03-09       Impact factor: 4.130

7.  Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma.

Authors:  Andrea R Di Sebastiano; Andrew Deweyert; Simon Benoit; Erin Iredale; Hu Xu; Cleusa De Oliveira; Eugene Wong; Susanne Schmid; Matthew O Hebb
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

Review 8.  A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma.

Authors:  John Trusheim; Erin Dunbar; James Battiste; Fabio Iwamoto; Nimish Mohile; Denise Damek; Daniela A Bota; Jennifer Connelly
Journal:  CNS Oncol       Date:  2016-09-15

9.  Molecular Evolution of a Glioblastoma Controlled With Tumor Treating Fields and Concomitant Temozolomide.

Authors:  H Ian Robins; HuyTram N Nguyen; Aaron Field; Steven Howard; Shahriar Salamat; Dustin A Deming
Journal:  Front Oncol       Date:  2018-10-15       Impact factor: 6.244

Review 10.  Tumor Treating Fields in the Management of Patients with Malignant Gliomas.

Authors:  Ashley P Ghiaseddin; David Shin; Kaitlyn Melnick; David D Tran
Journal:  Curr Treat Options Oncol       Date:  2020-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.